Literature DB >> 11217875

Iterative optimal design of PET experiments for estimating beta-adrenergic receptor concentration.

R F Muzic1, G M Saidel, N Zhu, A D Nelson, L Zheng, M S Berridge.   

Abstract

To estimate in vivo myocardial beta-adrenergic receptor concentration with sufficient precision and to reduce the experimental complexities in positron emission tomography (PET), an iterative optimal design method is applied. An initial three-injection protocol, utilising [F-18]-labelled (R)- and (S)-fluorocarazolol and unlabelled (S)-fluorocarazolol, is optimised for ligand dosages and administration times to maximise the precision of all model parameters using the D-optimal criterion. Using this experimental protocol, PET data are collected in porcine studies, and model parameters are estimated. All model parameters are identified with satisfactory precision. The in vivo myocardial beta-receptor concentration is 7.5+/-0.6 pmol x ml(-1), which corresponds to the in vitro result of 10.1+/-1.3 pmol x ml(-1). With more accurate parameter values, a simplified two-injection protocol is optimally designed, utilising only radiolabelled and unlabelled (S)-fluorocarazolol, based on a new criterion to maximise the precision of the beta-receptor concentration. This revised optimum design predicts that the in vivo beta-receptor concentration can be estimated with good precision but reduced experiment complexity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11217875     DOI: 10.1007/bf02344863

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  28 in total

1.  Continuous arterial positron monitor for quantitation in PET imaging.

Authors:  A D Nelson; R F Muzic; F Miraldi; G J Muswick; G P Leisure; W Voelker
Journal:  Am J Physiol Imaging       Date:  1990

Review 2.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Optimal design of experiments to estimate LDL transport parameters in arterial wall.

Authors:  E D Morris; G M Saidel; G M Chisolm
Journal:  Am J Physiol       Date:  1991-09

4.  Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography.

Authors:  J Delforge; A Syrota; B M Mazoyer
Journal:  Phys Med Biol       Date:  1989-04       Impact factor: 3.609

Review 5.  Regulation of beta-adrenergic receptors: impaired desensitization in myocardial ischemia.

Authors:  R H Strasser; J Krimmer; R Marquetant
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

6.  A new fast algorithm for the evaluation of regions of interest and statistical uncertainty in computed tomography.

Authors:  R H Huesman
Journal:  Phys Med Biol       Date:  1984-05       Impact factor: 3.609

7.  (S,S)- and (S,R)-1'-[18F]fluorocarazolol, ligands for the visualization of pulmonary beta-adrenergic receptors with PET.

Authors:  P H Elsinga; M G Vos; A van Waarde; A H Braker; T J de Groot; R L Anthonio; A A Weemaes; O E Brodde; G M Visser; W Vaalburg
Journal:  Nucl Med Biol       Date:  1996-02       Impact factor: 2.408

8.  Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist.

Authors:  L Zheng; M S Berridge; P Ernsberger
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

9.  Astrocytes cultured from specific brain regions differ in their expression of adrenergic binding sites.

Authors:  P Ernsberger; L Iacovitti; D J Reis
Journal:  Brain Res       Date:  1990-05-28       Impact factor: 3.252

10.  Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains.

Authors:  A Nordberg; A Adem; J Hardy; B Winblad
Journal:  Neurosci Lett       Date:  1988-04-12       Impact factor: 3.046

View more
  1 in total

1.  Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.